Evening primrose oil beneficial?

The short version: evening primrose oil has not been shown to work better than placebo for any common condition, despite decades of study.

The evidence for evening primrose oil (EPO) is a graveyard of null results. A 2016 review of 27 studies on EPO and borage oil for eczema found no significant improvement over placebo overall [1]. For breast pain (mastalgia), a 291-patient double-blind trial found a 45% response rate, but a 170-patient observational study found only 26% [2]. The larger trial compared EPO to a drug (danazol), not to placebo, so the real effect against doing nothing is unknown. For PMS, an open-label study showed 61% complete relief, but a subsequent double-blind trial of 38 women found no significant benefit [2]. The pattern is consistent: early positive results vanish when proper controls are added.

The only signal worth noting is in a 2006 intensive-care trial where an enteral formula containing EPA, GLA (the active fatty acid in EPO), and antioxidants was given to mechanically ventilated sepsis patients. The treated group had 19.4% lower absolute mortality and more ventilator-free days [3]. But that was a multi-component formula given to critically ill patients through a feeding tube, not a capsule of EPO taken by a healthy person. It tells you nothing about whether swallowing EPO helps eczema, PMS, or menopause.

The 2020 menopause trial that showed symptom improvement used a polyherbal capsule containing soy isoflavone, black cohosh, chasteberry, and EPO together [4]. You cannot isolate EPO's contribution from that mix. The 2011 Lady 4 trial showed a modest 7.5% extra improvement over placebo on a symptom scale [5], but again, EPO was one of several ingredients.

The mechanism story is plausible in theory. EPO provides gamma-linolenic acid (GLA), which the body can convert to anti-inflammatory prostaglandins. But the human body already makes GLA from dietary linoleic acid, and the conversion step (delta-6 desaturase) is rate-limited. Adding pre-formed GLA does not reliably shift the downstream profile in a way that produces clinical benefit in controlled trials.

My call: evening primrose oil is not worth taking for any common condition based on the existing evidence. The few positive signals come from multi-ingredient formulas or from critically ill patients on feeding tubes, not from EPO alone in the people who typically buy it. If you have eczema, PMS, or breast pain, the evidence says it works no better than a placebo capsule.

Confidence: high for eczema and PMS (multiple trials, consistent null); moderate for mastalgia (mixed results, no clean placebo comparison in the largest trial); low for any benefit from EPO alone in menopause (only tested in combination products).